Relationship between use test and threshold patch test concentration in patients sensitive to 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one (MCI/MI).
Menné
T
T
Department of Dermatology, Gentofte Hospital, Hellerup, Denmark.
D003877:Dermatitis, Contact / Q000175:diagnosis; D004311:Double-Blind Method; D006801:Humans; D010328:Patch Tests / Q000379:methods*; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*
D011310:Preservatives, Pharmaceutical; D013844:Thiazoles; C011506:2-methyl-4-isothiazolin-3-one; C011421:5-chloro-2-methyl-4-isothiazolin-3-one